Al mass (Da) 17148 16729 16371 13605 13463 12172 12041 11172 9688 9574 8358 7436 6278 Cleavage point 81 85 89 116 118 133 134 141 152 153 162 169 179 Peptide G81 – S232 G85 –

Al mass (Da) 17148 16729 16371 13605 13463 12172 12041 11172 9688 9574 8358 7436 6278 Cleavage point 81 85 89 116 118 133 134 141 152 153 162 169 179 Peptide G81 – S232 G85 – S232 G89 – S232 A116 – S232 G118 – S232 M133 – S232 S134 – S232 G141 – S232 N152 – S232 M153 – S232 Y162 – S232 S169 – S232 V179 – S*Entries sharing a color represent PK-resistant peptides of very similar MW that were not resolved on the tricine gel. doi:10.1371/journal.pone.0050111.tStructural Organization of Mammalian PrionsFigure 3. Western blot analysis of PK-resistant GPI2 PrPSc. Unpurified GPI- PrPSc was treated with 25 mg/ml of PK and subsequently deglycosylated with PNGase F. Samples were resolved on Tricine-SDSPAGE and probed with the monoclonal antibodies, #51 (lane 1), W226 (lane 2), and R1 (lane 3). doi:10.1371/journal.pone.0050111.gZou et al. described human CJD PrPSc PK-resistant C-terminal peptides spanning from positions 154/156 and 162/167 to the Cterminus [19]. These fragments are analogous to GPI- PrPSc peptides N152-S232/M153-S232 and Y162-S232, S169-S232, respectively. Zanusso et al. described two additional amino-terminally truncated human CJD PrPSc peptides (MW of 16/17 kDa) [20], analogous to the GPI- PrPSc peptides G141-S232 and M133-S232/ S134-S232. Kocisko et al. used a C-terminal antibody (epitope 217232) to demonstrate the presence of a number of amino-terminally truncated PK-resistant species in SHaPrPSc [18]. Using synthetic mouse prions, Bocharova et al. identified the regions beginning at 138/141, 152/153, and 162, and extending to the C-terminus as being resistant to PK [21]. This suggests that synthetic prions and PrPSc share key structural elements, which would explain the capacity of recombinant PrP fibrils to change their conformation, via a “deformed templating” mechanism, to that of PrPSc [22]. In contrast, relatively few MedChemExpress Tubastatin-A C-terminally truncated peptides have been described. Notari et al. reported two human CJD PrPSc peptides truncated near position 228 [23]. Stahl et al. also reported the presence of a peptide truncated at position 228 in PK-treatedSHaPrPSc [24]. The absence of such fragments in our study could be explained by slight differences in sample preparation, or perhaps by the fact that the absence of the GPI-anchor might have an effect on nearby residues. This conspicuous absence of the C-terminally truncated peptides is a reflection of the stability of the C-terminal region, in GPI2 PrPSc appears to be the most stable part of the molecule, which is inconsistent with the presence of substantial stretches of ahelical secondary structure in that region. Our results agree with Smirnovas et al., who showed the C-terminus of GPI- PrPSc to exhibit extremely low rates of H/D exchange, typical of extensive H-bonding (b-sheet) [9]. These authors showed that an FTIR absorbance band (,1,660 cm21) previously assigned to a-helical secondary structure in PrPSc is also present in the spectrum of recombinant PrP order Alprenolol amyloid fibrils, which contain no a-helices, and therefore cannot be taken as evidence of the presence of a-helical structure. They concluded that GPI2 PrPSc consists of a series of b-sheet stretches connected by short loops and/or turns, in agreement with our conclusions. Some stretches exhibiting a somewhat higher exchange rate, suggested to overlap with loops/ turns, such as 133?48 or 81?18, are consistent with flexible stretches identified 1407003 in our study, although discrepancies also exist. The limited resolution of both.Al mass (Da) 17148 16729 16371 13605 13463 12172 12041 11172 9688 9574 8358 7436 6278 Cleavage point 81 85 89 116 118 133 134 141 152 153 162 169 179 Peptide G81 – S232 G85 – S232 G89 – S232 A116 – S232 G118 – S232 M133 – S232 S134 – S232 G141 – S232 N152 – S232 M153 – S232 Y162 – S232 S169 – S232 V179 – S*Entries sharing a color represent PK-resistant peptides of very similar MW that were not resolved on the tricine gel. doi:10.1371/journal.pone.0050111.tStructural Organization of Mammalian PrionsFigure 3. Western blot analysis of PK-resistant GPI2 PrPSc. Unpurified GPI- PrPSc was treated with 25 mg/ml of PK and subsequently deglycosylated with PNGase F. Samples were resolved on Tricine-SDSPAGE and probed with the monoclonal antibodies, #51 (lane 1), W226 (lane 2), and R1 (lane 3). doi:10.1371/journal.pone.0050111.gZou et al. described human CJD PrPSc PK-resistant C-terminal peptides spanning from positions 154/156 and 162/167 to the Cterminus [19]. These fragments are analogous to GPI- PrPSc peptides N152-S232/M153-S232 and Y162-S232, S169-S232, respectively. Zanusso et al. described two additional amino-terminally truncated human CJD PrPSc peptides (MW of 16/17 kDa) [20], analogous to the GPI- PrPSc peptides G141-S232 and M133-S232/ S134-S232. Kocisko et al. used a C-terminal antibody (epitope 217232) to demonstrate the presence of a number of amino-terminally truncated PK-resistant species in SHaPrPSc [18]. Using synthetic mouse prions, Bocharova et al. identified the regions beginning at 138/141, 152/153, and 162, and extending to the C-terminus as being resistant to PK [21]. This suggests that synthetic prions and PrPSc share key structural elements, which would explain the capacity of recombinant PrP fibrils to change their conformation, via a “deformed templating” mechanism, to that of PrPSc [22]. In contrast, relatively few C-terminally truncated peptides have been described. Notari et al. reported two human CJD PrPSc peptides truncated near position 228 [23]. Stahl et al. also reported the presence of a peptide truncated at position 228 in PK-treatedSHaPrPSc [24]. The absence of such fragments in our study could be explained by slight differences in sample preparation, or perhaps by the fact that the absence of the GPI-anchor might have an effect on nearby residues. This conspicuous absence of the C-terminally truncated peptides is a reflection of the stability of the C-terminal region, in GPI2 PrPSc appears to be the most stable part of the molecule, which is inconsistent with the presence of substantial stretches of ahelical secondary structure in that region. Our results agree with Smirnovas et al., who showed the C-terminus of GPI- PrPSc to exhibit extremely low rates of H/D exchange, typical of extensive H-bonding (b-sheet) [9]. These authors showed that an FTIR absorbance band (,1,660 cm21) previously assigned to a-helical secondary structure in PrPSc is also present in the spectrum of recombinant PrP amyloid fibrils, which contain no a-helices, and therefore cannot be taken as evidence of the presence of a-helical structure. They concluded that GPI2 PrPSc consists of a series of b-sheet stretches connected by short loops and/or turns, in agreement with our conclusions. Some stretches exhibiting a somewhat higher exchange rate, suggested to overlap with loops/ turns, such as 133?48 or 81?18, are consistent with flexible stretches identified 1407003 in our study, although discrepancies also exist. The limited resolution of both.

Leave a Reply